Sun’s Caraco Unit To Close US Factory Despite FDA Clearance
This article was originally published in PharmAsia News
Executive Summary
A U.S. plant owned by Caraco Pharmaceutical Laboratories, a unit of India’s Sun Pharmaceuticals Industries, is set to be closed instead of resuming production that was halted by the U.S. FDA in 2009.